Holen Sie sich die Stockscreener-App
28.07
4.14%
0.51
Handel nachbörslich:
28.07
Schlusskurs vom Vortag:
$27.56
Offen:
$27.42
24-Stunden-Volumen:
30,321
Relative Volume:
0.34
Marktkapitalisierung:
$1.23B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.58%
1M Leistung:
-33.53%
6M Leistung:
+347.74%
1J Leistung:
+0.00%
1-Tages-Spanne:
$26.05
$28.90
1-Wochen-Bereich:
$26.05
$33.50
52-Wochen-Spanne:
$5.60
$55.65
Anbio Biotechnology Stock (NNNN) Company Profile
Vergleichen Sie NNNN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NNNN
Anbio Biotechnology
|
28.07 | 1.21B | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
436.39 | 156.20B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
188.35 | 53.50B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
270.15 | 39.84B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
74.08 | 35.89B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
261.26 | 18.87B | 2.96B | 487.70M | 344.00M | 6.6758 |
Anbio Biotechnology Aktie (NNNN) Neueste Nachrichten
Why Anbio Biotechnology’s Stock is Tumbling - TipRanks
Anbio Biotechnology’s Hype And Hard Approvals Suggest A Stretched Valuation (NNNN) - Seeking Alpha
Anbio Biotechnology prices $8M IPO at $5 per share - MSN
Driving Veterinary Healthcare Forward: Anbio Showcases Diagnostic Portfolio at WSAVA 2025 - digitalmore.co
Trump Sparks A 2025 IPO Boom: 5 New Stocks Have Rallied Over 400% - inkl
Anbio Biotechnology Class A Shares Take a Tumble - TipRanks
White Mountains Insurance, Rumble, Mesoblast And Other Big Stocks Moving Higher On Friday - Benzinga
Dow Jumps Over 200 Points; ISM Services PMI Falls In September - inkl
S&P 500 Futures Rise in Premarket Trading; Anbio Biotechnology, Rigetti Computing Lead - Barron's
Anbio Biotechnology Stock Tumbles Amid Volatility - TipRanks
Liverpool Ferry Port Faces Repairs Due to Berth Damage - Berawang News
Jake LaRavia Talks Lakers Role After JJ Redick’s Media Day Insights - Berawang News
Manchester United legend wants Arsenal to win the league – Daily Cannon - Berawang News
Will RSVR stock go up soonJuly 2025 Gainers & Capital Protection Trading Alerts - newser.com
What does recent volatility data suggest for GAN Limited2025 Market Outlook & High Conviction Buy Zone Alerts - newser.com
What the charts say about Deswell Industries Inc. todayTrade Volume Summary & Fast Moving Market Watchlists - Newser
Visual trend scoring systems applied to Puma Biotechnology Inc.Trade Volume Summary & Fast Exit Strategy with Risk Control - Newser
Is AMZE showing signs of accumulationEarnings Overview Report & Real-Time Buy Zone Alerts - Newser
Sentiment Turns Positive on ASGN Incorporated — Reversal AheadWeekly Stock Report & Daily Momentum Trading Reports - beatles.ru
Is Climb Bio Inc. showing signs of accumulation2025 Trade Ideas & High Conviction Investment Ideas - Newser
Are Bears Losing Grip on BLFS? getLinesFromResByArray error: size == 0 - 더경남뉴스
Analyzing Share Issuance and Voting Rights Dynamics in Growth-Stage Biotechs: Navigating Governance and Dilution Risks - AInvest
What earnings revisions data tells us about iBio Inc.2025 Big Picture & Real-Time Chart Breakout Alerts - Newser
LKY(linkey) Project ReviewTrade Exit Summary & Safe Entry Zone Identification - Newser
Is ACCESS Newswire Inc. forming a bottoming base2025 Year in Review & Expert Verified Movement Alerts - Newser
Real time breakdown of Graham Holdings Company stock performance2025 Breakouts & Breakdowns & Growth Oriented Trading Recommendations - Newser
Is ZVIA stock poised for growthDollar Strength & Free High Accuracy Swing Entry Alerts - Newser
Technical signs of recovery in Fortive Corporation2025 Big Picture & Technical Entry and Exit Alerts - Newser
How High Can FHE(mind network) Go2025 EndofYear Setup & Safe Entry Zone Tips - Newser
Will Grayscale Ethereum Trust outperform the marketJuly 2025 Catalysts & Weekly Breakout Stock Alerts - Newser
Live market analysis of HJJ CLMarket Movement Recap & Verified Technical Signals - Newser
Top Reasons to Buy PIX(pixelswap)July 2025 Weekly Recap & Capital Efficiency Focused Ideas - Newser
What recovery options are there for RGC Resources Inc.Market Growth Review & Fast Exit and Entry Trade Guides - Newser
Arista Networks Volume Dives 27.46 to 97th Rank Amid Record Earnings and Analyst Upgrades - AInvest
Why Rapid7 Inc. stock attracts strong analyst attention2025 Sector Review & Risk Adjusted Buy/Sell Alerts - Newser
Is Greenland Technologies Holding Corporation’s ROE strong enoughRate Hike & Weekly High Conviction Trade Ideas - sundaytimes.kr
Should you hold or exit HONE nowLayoff News & Accurate Buy Signal Notifications - Newser
Can machine learning forecast TMUS recoveryEarnings Beat & Technical Buy Zone Confirmation - Newser
How do analysts view the current valuation of Nasdaq stocks? - AInvest
News impact scoring models applied to Cmb.Tech NVWall Street Watch & Daily Profit Focused Screening - Newser
How to read the order book for STRRPMarket Movers & Real-Time Chart Breakout Alerts - Newser
Leading vs lagging indicators on ETI.PR performanceFed Meeting & High Accuracy Swing Entry Alerts - Newser
The Unlocking of Voting Control in Anbio Biotechnology: A Post-Lock-Up Opportunity in a Dual-Class IPO - AInvest
Anbio Biotechnology's Post-Lock-Up Investment Implications: Unlocking Shareholder Value and Market Dynamics - AInvest
Anbio Biotechnology Class A Ordinary Shares Subject to Lock-Up Agreement Ending August 18, 2025. - AInvest
Certain Class B Ordinary Shares of Anbio Biotechnology are subject to a Lock-Up Agreement Ending on 18-AUG-2025. - MarketScreener
Can MNTK expand its profit marginsMarket Trend Review & AI Forecasted Stock Moves - thegnnews.com
Will Aquestive Therapeutics Inc. price bounce be sustainablePortfolio Growth Summary & High Accuracy Swing Entry Alerts - Newser
Certain Class A Ordinary Shares of Anbio Biotechnology are subject to a Lock-Up Agreement Ending on 18-AUG-2025. - MarketScreener
CompanyInsider Selling & Reliable Breakout Stock Forecasts - Newser
Zhengye Skyrocketed 33.84%—What’s Fueling This Biotech Breakout? - AInvest
Finanzdaten der Anbio Biotechnology-Aktie (NNNN)
Es liegen keine Finanzdaten für Anbio Biotechnology (NNNN) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.91%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):